X

Granules India Ltd Q4FY24; 8% rise in Profits

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.

Financial Results:

Granules India Ltd reported Revenues for Q4FY24 of ₹1,176.00 Crores down from ₹1,196.00 Crore year on year, a fall of 1.67%.

Total Expenses for Q4FY24 of ₹1,002.00 Crores down from ₹1,035.00 Crores year on year, a fall of 3.19%.

Consolidated Net Profit of ₹130.00 Crores up 8.33% from ₹120.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹5.35, up 8.30% from ₹4.94 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post